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TECHNICAL NOTE
Quantitative assessment of fibrinolysis on isolated glomeruli
JEAN-DANIEL SRAER, JOHAN BOELAERT,
ODILE MIMOUNE, LILIANE MOREL-MAROGER and HELENA HORNYCH
Unite de Recherches de Nephrologie Normale et Pathologique de l'INSERM U64, Hôpital Tenon, Paris, France
Since its original description by Todd [1], the fibrin slide
technique has been used to study the localization of
fibrinolytic activity in various tissues. Our preliminary
results indicate that glomerular fibrinolysis can be measured
quantitatively using a preparation of isolated glomeruli.
Methods. 1) Preparation of isolated glomeruli. This
technique was derived from that of Fong and Drum-
mond [2]. Adult rats (Charles River strain) weighing ap-
proximately 120 g, were anesthetized with ether. Their
kidneys were carefully removed by a mid-abdominal in-
cision and were not flushed. The outer cortex was dissected
with scissors, immediately cooled at 0°C, minced to paste-
like consistency with a razor blade and suspended in 1/15 M
phosphate buffer, pH 7.6 at 0°C. Centrifugation was
carried out for 90 seconds with the speed-control set to give
a maximal of 120G. The supernatant was discarded and the
pellet was suspended again and centrifuged. After seven
repetitions of this procedure, the pellet, containing isolated
glomeruli without their Bowman's capsule, was added to
the fibrinogen solution.
2) Preparation of the fibrin slides. This technique was
derived from that of Kwaan and Astrup [3]. Human plas-
minogen-rich fibrinogen containing factor XIII (Centre
National de Transfusion Sanguine, Paris, France) was used
at 1.5% in 1/15 M phosphate buffer, pH 7.6. Thrombin
(Hoffman LaRoche, Basel, Switzerland) was diluted in
saline (20 NIH units/mi) and layered upon a demarcated
area of a glass slide (5 x 2.5 cm). By placing the slide
vertically on blotting paper, residual thrombin was re-
moved and a thin thrombin film was obtained. 0.2 ml of
the fibrinogen solution, containing the glomerular suspen-
sion, was spread over the thrombin, thus forming a homo-
geneous fibrin film (160 j.t thick) containing isolated gb-
meruli. Slides were kept horizontally during 1 minute at
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room temperature for clot formation and transferred into
a moist chamber at 37°C for periods ranging from 30 to
120 minutes. After incubation, fibrin slides were fixed in
4% formaldehyde (pH 7) for one hour at room temperature,
rinsed with water, stained with Harris hematoxylin (with-
out acetic acid) for 15 mm, again rinsed with water,
mounted with Permount (Serlabo, Paris), coverslipped and
sealed with nail polish.
3) Measurement of glomerular fibrinolysis. As areas of
fibrinolysis around glomeruli appear as lytic defects in the
fibrin film, the ratio of the diameter of the lytic area over
that of the glomerular tuft (Fig. 1) was measured micro-
scopically (with a graduated ocular) on at least 12 well-
isolated glomeruli of each slide and taken as the "fibrino-
lytic index."
Results (Fig. 2). 1) Results with the described technique:
Control group (N = 8). Glomerular fibrinolysis appeared
after 22 to 28 mm of incubation. The fibrinolytic index was
highly correlated to incubation time (P <0.001) in each
rat studied. The mean slope and the mean intercept of the
regression lines were 0.028 0.00235 min1 and 0.2967
0.1006, respectively. Two factor (rat and incubation time)
variance analysis was performed, which disclosed no
statistical difference between individual rats.
2) Effect of modification of experimental conditions. For
each of these studies, the regression line fibrinolytic index
versus time was plotted for individual rats and its slope
calculated. The mean slope of each group was then com-
pared by Student's t test to that obtained in the control
group. a) Modification of the fibrinogen concentration
(N= 3). Fibrin plates were made with a fibrinogen solution
using various concentrations (0.7, 3.0 and 6.0%) and
compared to the control ones (concentration of 1.5%).
Fibrinolysis was significantly lower at the two higher con-
centrations (P<0.01 with the 6% fibrinogen solution and
P <0.001 with the 3% one). On the other hand, there was
1 N=number of rats.
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Fig. 1. Photomicrograph of fibri-
nolysis around an isolated rat gb-
merulus after 75 mm of incubation
at 37°C. (x 250).
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no significant difference for the lower concentration.
b) Storage of kidneys at _200 C for 3 to 12 weeks (N =8).
The second kidney from each control rat was frozen im-
mediately after removal and stored as a whole. Storage
did not significantly affect fibrinolytic activity. c) Fibrin
slides without plasminogen (N= 2). These were prepared
by spreading 0.2 ml of fibrinogen solution, before the
addition of glomeruli, over the thrombin-containing slides.
After clotting, the fibrin slides were maintained in a moist
chamber at 80°C for 1 hour [4]. Approximately 0.1 ml of
the suspension of isolated glomeruli was then spread over
the fibrin film, and the slide was incubated at 37°C for as
long as 180 mm. No fibrinolysis could be observed.
Layering the glomeruli over the surface of the plasminogen-
Fig. 2. "Fibrinolytic index" versus incubation time. Left: each
slope corresponds to an individual "control" rat; Right: mean
slope in various experimental conditions: 1) control, 2) storage
at — 20°C, 3,4 and 5) fibrinogen concentrations of 0.7, 3 and
6%, respectively.
containing fibrin slide or incorporating them within the
film yielded no difference in fibrinolytic activity. d) Enrich-
ment offibrinogen by addition of human plasminogen (N = 3).
Plasminogen (Centre National de Transfusion Sanguine,
Paris) was added to the fibrinogen solution at concentra-
tion of 0.1, 0.2 and 0.4mg per ml. At these concentrations,
fibrinolysis was not significantly modified. e) Inhibition of
glomerularfibrinolysis by synthetic inhibitors of plasminogen
activators: Epsilon-amino-caproic acid and tranexamic acid
(N=4). In vitro addition of epsilon-amino-caproic acid
iO M (Hemocaprol, Delagrange, Paris) (N=2) and of
tranexamic acid i0— M (Frenolyse, Specia, Paris) (N =2)
to the fibrinogen solution resulted in a total inhibition of
fibrinolysis for an incubation period up to 120 mm.
Discussion. The method described here attempts to in-
vestigate glomerular fibrinolysis on a quantitative basis.
When studied by the usual fibrin plate technique applied
on kidney tissue sections, fibrinolysis appears earlier around
blood vessels than around glomeruli [5]. Accurate meas-
urement of glomerular fibrinolysis is thus difficult because
more active areas in the section produce confluent zones of
lysis after brief periods of incubation. As a purified suspen-
sion of isolated glomeruli was used in the present study,
our technique enables glomerular fibrinolysis to be sepa-
rated from that of other renal structures, mainly vascular
and tubular [5, 6]. Whereas the usual fibrin plate technique,
applied on renal tissue sections, appreciates either "focal
lysis time" qualitatively [3] or, more recently, semi-quanti-
tatively [7], the present method yields quantitative, highly
reproducible results. Glomerular fibrinolysis appeared at
22 to 28 mm after starting the incubation at 37° C. As a
similar time is reported [6] using whole kidney tissue sec-
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tions, it is unlikely that the isolation procedure of the
glomeruli alters their lytic activity. The limiting factor, at
any given fibrinogen concentration, was the amount of
tissue activator present: indeed, the fibrinogen used was
rich in plasminogen, and the addition of plasminogen did
not enhance fibrinolytic activity. In the present method as
well as in the fibrin plate technique applied on tissue sec-
tions, fibrinolysis is due to specific glomerular plasminogen
activators and not to nonspecific proteases. Indeed, the
use of fibrin in which plasminogen was heat-denaturated [4]
resulted in complete inhibition of fibrinolysis. Likewise,
in vitro addition of either epsilon-amino-caproic acid or
tranexamic acid, both synthetic inhibitors of plasminogen
activation, also led to disappearance of glomerular fibrino-
lysis. Since the preparation of isolated glomeruli yields a
suspension of glomerular tufts without Bowman's capsule,
the glomerular plasminogen activator is localized within
the tuft, as suggested by previous authors [6]. However, its
more precise localization at the cellular level was not yet
possible. Kidney storage at _200C up to 12 weeks did not
alter fibrinolytic activity: this finding confirms the results of
previous studies [3, 6]; moreover, it emphasizes the re-
producibility of our quantitative method, as renal tissue
from the same animal was examined at different times.
Previous qualitative studies in man and animals have
attempted to evaluate the fibrinolysis of renal tissue in
normal as well as in pathological conditions. This new
quantitative method should allow more accurate studies of
pathological glomerular fibrinolysis.
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